The impact that new innovations has had on the NHS is set out in the  Accelerated Access Collaborative’s (AAC) report, Our Year in Focus 2019/20. The report reveals how over 700,000 patients were provided with access to proven innovations supported by the AAC, resulting in estimated patient benefits of over 12,000 fewer hospital admissions and 125,000 fewer days spent in hospital. Across the AAC programmes this work has saved the NHS over £50million.

The AAC, hosted by NHS England and NHS Improvement, sets the strategy for the entire health innovation ecosystem. It is a partnership between patient groups, government bodies, industry and NHS bodies, working together to streamline the adoption of new innovations in healthcare.  In its first year of operation with its expanded remit, AAC programmes attracted over £450million of investment and created or safeguarded over 1,500 jobs.

In addition, the AAC’s central role facilitating stakeholder collaborations, underpinned by horizon-scanning intelligence, meant early in the pandemic it was able to work with partners to rapidly progress the UK’s world leading COVID-19 research into COVID therapeutics. This work helped contribute to the introduction of three lifesaving COVID-19 treatments becoming available to NHS patients in record time and a further two have since followed suit.

The AAC is committed to getting more proven innovations to patients and clinicians faster and making the NHS a great place to innovate for the benefit of patients and the public.

Read the review, hear from its’ Chief Executive, Matt Whitty, and learn more about how it can help you and your staff to innovate by visiting Accelerated Access Collaborative’s webpages